Daiwa Securities Group Inc. - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$20
+100.0%
5200.0%0.00%
Q2 2023$10
+25.0%
5200.0%0.00%
Q1 2023$8
-11.1%
5200.0%0.00%
Q4 2022$9
-99.6%
520
+32.0%
0.00%
Q3 2022$2,0000.0%3940.0%0.00%
Q2 2022$2,0000.0%3940.0%0.00%
Q1 2022$2,000
-33.3%
3940.0%0.00%
Q4 2021$3,0000.0%3940.0%0.00%
Q3 2021$3,000
+50.0%
394
+114.1%
0.00%
Q2 2021$2,000
-33.3%
1840.0%0.00%
Q1 2021$3,000
-62.5%
1840.0%0.00%
Q4 2020$8,0001840.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,510,412$264,291,0006.36%
Ghost Tree Capital, LLC 525,000$18,475,0005.34%
Pinz Capital Management, LP 199,100$7,006,0002.56%
ACUTA CAPITAL PARTNERS, LLC 250,000$8,798,0002.39%
BVF INC/IL 1,198,427$42,173,0002.30%
Cormorant Asset Management, LP 1,637,951$57,639,0002.22%
Vivo Capital, LLC 1,042,460$36,684,0002.12%
Parkman Healthcare Partners LLC 150,151$5,284,0001.40%
MANGROVE PARTNERS IM, LLC 230,307$8,105,0001.02%
Ikarian Capital, LLC 321,887$11,328,0000.82%
View complete list of IMMUNOVANT INC shareholders